title: Dr. Spaans and colleagues reply.
authors.affiliation: Department of Psychiatry hp.spaans@parnassia.nl.
authors.forename: Harm-Pieter
authors.initials: HP
authors.lastname: Spaans
authors.forename: Esmée
authors.initials: E
authors.lastname: Verwijk
authors.forename: Pascal
authors.initials: P
authors.lastname: Sienaert
authors.forename: Max L
authors.initials: ML
authors.lastname: Stek
authors.forename: Filip
authors.initials: F
authors.lastname: Bouckaert
authors.forename: Hannie C
authors.initials: HC
authors.lastname: Comijs
authors.forename: Rob M
authors.initials: RM
authors.lastname: Kok
authors.forename: Erik J A
authors.initials: EJ
authors.lastname: Scherder
authors.forename: King H
authors.initials: KH
authors.lastname: Kho
mesh_terms: D001714:Bipolar Disorder / Q000628:therapy*; D003072:Cognition Disorders / Q000209:etiology* / Q000517:prevention & control*; D003865:Major Depressive Disorder / Q000628:therapy*; D004565:Electroconvulsive Therapy / Q000009:adverse effects* / Q000379:methods*; D005260:Female; D006801:Humans; D008297:Male